These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14638362)

  • 1. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
    Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of decay-accelerating factor into stools of patients with colorectal cancer by means of cleavage at the site of glycosylphosphatidylinositol anchor.
    Kawada M; Mizuno M; Nasu J; Uesu T; Okazaki H; Okada H; Shimomura H; Yamamoto K; Tsuji T; Fujita T; Shiratori Y
    J Lab Clin Med; 2003 Nov; 142(5):306-12. PubMed ID: 14647034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of protein p53 in the stool of patients with colorectal cancer].
    Jaïs P; Kapel N; Chosidow D; Rupaire N; Rougier P; Lasser P; Mignon M; Lewin MJ; Gobert JG
    Gastroenterol Clin Biol; 1997; 21(10):754-9. PubMed ID: 9587516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of calgranulin B in stools from the patients with colorectal cancer.
    Yoo BC; Shin YK; Lim SB; Hong SH; Jeong SY; Park JG
    Dis Colon Rectum; 2008 Nov; 51(11):1703-9. PubMed ID: 18584251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stool decay-accelerating factor as a marker for monitoring the disease activity during leukocyte apheresis therapy in patients with refractory ulcerative colitis.
    Kohno H; Mizuno M; Nasu J; Makidono C; Hiraoka S; Inaba T; Yamamoto K; Okada H; Fujita T; Shiratori Y
    J Gastroenterol Hepatol; 2005 Jan; 20(1):73-8. PubMed ID: 15610450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of different stool tests for the detection of cancer of the colon].
    Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G
    Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of decay-accelerating factor in stool specimens of patients with colorectal cancer.
    Mizuno M; Nakagawa M; Uesu T; Inoue H; Inaba T; Ueki T; Nasu J; Okada H; Fujita T; Tsuji T
    Gastroenterology; 1995 Sep; 109(3):826-31. PubMed ID: 7544751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.
    Limburg PJ; Devens ME; Harrington JJ; Diehl NN; Mahoney DW; Ahlquist DA
    Am J Gastroenterol; 2003 Oct; 98(10):2299-305. PubMed ID: 14572583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal lysozyme: an unreliable marker for colorectal cancer.
    Dubrow R; Kim CS; Eldred AK
    Am J Gastroenterol; 1992 May; 87(5):617-21. PubMed ID: 1595650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of stool DNA mutations before and after treatment of colorectal neoplasia.
    Syngal S; Stoffel E; Chung D; Willett C; Schoetz D; Schroy P; Jagadeesh D; Morel K; Ross M
    Cancer; 2006 Jan; 106(2):277-83. PubMed ID: 16342248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.
    Kim Y; Lee S; Park S; Jeon H; Lee W; Kim JK; Cho M; Kim M; Lim J; Kang CS; Han K
    Ann Clin Lab Sci; 2003; 33(1):32-8. PubMed ID: 12661896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
    Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
    Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
    Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls.
    Hardt PD; Toepler M; Ngoumou B; Rupp J; Kloer HU
    Anticancer Res; 2003; 23(2A):851-3. PubMed ID: 12820312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
    Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis.
    Okazaki H; Mizuno M; Nasu J; Makidono C; Hiraoka S; Yamamoto K; Okada H; Fujita T; Tsuji T; Shiratori Y
    J Lab Clin Med; 2004 Mar; 143(3):169-74. PubMed ID: 15007307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer.
    Loktionov A; O'Neill IK; Silvester KR; Cummings JH; Middleton SJ; Miller R
    Clin Cancer Res; 1998 Feb; 4(2):337-42. PubMed ID: 9516920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Colorectal exfoliated cell in stool and its nuclear DNA quantitative analysis for diagnosis of colorectal cancer].
    Fan RY; Li SR; Wu ZT; Wu X; Chen ZM
    Ai Zheng; 2002 Jul; 21(7):776-80. PubMed ID: 12479106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.
    Zhang W; Bauer M; Croner RS; Pelz JO; Lodygin D; Hermeking H; Stürzl M; Hohenberger W; Matzel KE
    Dis Colon Rectum; 2007 Oct; 50(10):1618-26; discussion 1626-7. PubMed ID: 17762966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.